SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #1,552CAS 2区Hybrid

Lung Cancer

Abbreviation (ISO):LUNG CANCER
Country: Netherlands•WoS SCIE Quartile: Q1•Scopus SJR: 1.928•SCImago Rank: #1,552•Identifier (ISSN):0169-5002(Print)/1872-8332(Online)•Articles / Year: 271•Estimated Publication Fee (APC): $3,667 USD
Clarivate IF (2026)Q1
5.3
↑ +0.9

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
114

114 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate2.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
271articles/year
30.75% Gold OA•91.9% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 5.3)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.3)
🔵 Computed
20252.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.4)
🔵 Computed
20242.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.5)
🔵 Computed
20233.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.3)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 6.081)
🔵 Computed
20213.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.705)
🔵 Computed
20202.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.702)
🔵 Computed
20192.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.599)
🔵 Computed
20182.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.486)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.

Topics Covered (Recognized by AI)
MedicineInternal MedicinePathologyOncologyBiologyGeneticsSurgeryOncology & Cancer ResearchChemistryPhilosophyLinguisticsBiochemistryRadiology
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,552Scopus Q1SCImago Profile
Scopus Coverage:1985-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.928

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
160

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
4.93

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,667 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations3,439
3-Year Documents678
Citable Documents636

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate37.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
OncologyQ1
Pulmonary and Respiratory MedicineQ1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
5.9周
Average time to first editorial decision
Online Publication Speed
3.1周
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Elsevier Ireland Ltd
Publication Language
English
Frequency
Monthly
Founding Year
1985
Editorial Address
ELSEVIER IRELAND LTD, ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, IRELAND, 00000
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRSCIE
80/333Q1
RESPIRATORY SYSTEM
JCRSCIE
16/107Q1
ONCOLOGY
JCISCIE
68/333Q1
RESPIRATORY SYSTEM
JCISCIE
21/107Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—592105
20254.48511,152
20244.56142,182
20235.36003,263
20226.0814264,213
20215.7056056,674
20204.7027449,640
20194.59973713,014
20184.48672013,664
2017—61012,870
2016—48511,475
2015—49812,577
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Lung Cancer

WoS Q1
3467201820192020202120222023202420254.40
Annual Impact Factor Metric
2025:4.4

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 18758332-aef4-407d-8282-e7fef27a2a22
Database Updated: 2026-09-28